TY - JOUR
T1 - Cytomegalovirus disease
T2 - Can it be prevented?
AU - Balfour, H. H.
PY - 1983/1/1
Y1 - 1983/1/1
N2 - The question posed by this editorial may be answered with a hesitant yes. Passive immunization has been shown to prevent cytomegalovirus disease in certain bone marrow transplant recipients, interferon has an antiviral effect in renal transplant patients, acyclovir is worth a try, and cytomegalovirus vaccine has been associated with a lower incidence of cytomegalovirus disease after renal transplantation. Although we are not exactly galloping toward the goal of eliminating cytomegalovirus disease, we seem to be walking in the right direction.
AB - The question posed by this editorial may be answered with a hesitant yes. Passive immunization has been shown to prevent cytomegalovirus disease in certain bone marrow transplant recipients, interferon has an antiviral effect in renal transplant patients, acyclovir is worth a try, and cytomegalovirus vaccine has been associated with a lower incidence of cytomegalovirus disease after renal transplantation. Although we are not exactly galloping toward the goal of eliminating cytomegalovirus disease, we seem to be walking in the right direction.
UR - http://www.scopus.com/inward/record.url?scp=0020630813&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020630813&partnerID=8YFLogxK
U2 - 10.7326/0003-4819-98-4-544
DO - 10.7326/0003-4819-98-4-544
M3 - Article
C2 - 6188395
AN - SCOPUS:0020630813
SN - 0003-4819
VL - 98
SP - 544
EP - 546
JO - Annals of internal medicine
JF - Annals of internal medicine
IS - 4
ER -